Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system. Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity to the protein networks implicated in neurodegeneration and parkinsonism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar phenotype has also been described in the context of loss‐of‐function mutations in the P‐type ATPase gene ATP13A2, in which recessive, early‐onset PD has been linked to defective acidification of lysosomes and insufficient autophagy (Ramirez et al, 2006).”
From Autophagy in major human diseases (2021) · cites this paper as Ramirez et al, 2006
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“By mutation screening or linkage analysis, we excluded the known autosomal recessive Parkinson disease genes and loci: PARK2 (also known as Parkin ; ref”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Evolution of Substrate Specificities in the P-Type ATPase Superfamily
Axelsen, K. B., & Palmgren, M. G. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00006286 · Cited by 910
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Cited by
Items 501–600 of 1,000
ATP13A2variability in Parkinson disease
Vilariño‐Güell, C., Soto, A. I., Lincoln, S., Yahmed, S. B., Kefi, M., Heckman, M. G., Hulihan, M., Chai, H., Diehl, N. N., Amouri, R., et al. (2008) · Human Mutation · doi:10.1002/humu.20877 · Cited by 45
Cook, L. P., Schulze, J., Farlow, J. L., Pankratz, N., Wojcieszek, J., & Foroud, T. (2014) · Europe PMC (PubMed Central) · Cited by 46
Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
Wallom, K., Fernández‐Suárez, M. E., Priestman, D. A., Vruchte, D. T., Huebecker, M., Hallett, P. J., Isacson, O., & Platt, F. M. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10023-x · Cited by 47
What have we learned from Drosophila models of Parkinson’s disease?
Guo, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84001-4 · Cited by 51
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Valadas, J. S., Vos, M. H., & Verstreken, P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12577 · Cited by 45
Roth, J. A. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.08.006 · Cited by 48
Schlaudraff, F., Gründemann, J., Fauler, M., Dragicevic, E., Hardy, J., & Liss, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.016 · Cited by 47
Self-citationEndolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges
Kett, L. R., & Dauer, W. T. (2016) · Movement Disorders · doi:10.1002/mds.26797 · Cited by 42
Kolářová, H., Tan, J., Strom, T. M., Meitinger, T., Wagner, M., & Klopstock, T. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103869 · Cited by 46
Wu, G., Yan, B., Wang, X., Feng, X., Zhang, A., Xu, X., & Dong, H. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.011 · Cited by 45
Genetics of movement disorders in the next‐generation sequencing era
Olgiati, S., Quadri, M., & Bonifati, V. (2016) · Movement Disorders · doi:10.1002/mds.26521 · Cited by 45
Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2025) · ACS Omega · doi:10.1021/acsomega.4c09114 · Cited by 45
Emerging links between pediatric lysosomal storage diseases and adult parkinsonism
Ysselstein, D., Shulman, J. M., & Krainc, D. (2019) · Movement Disorders · doi:10.1002/mds.27631 · Cited by 40
Lee, Y.-T. C., & Hsu, S. D. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203717666160217143721 · Cited by 42
Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02472-0 · Cited by 42
Sepúlveda, D., Cisternas-Olmedo, M., Arcos, J., Nassif, M., & Vidal, R. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805087 · Cited by 42
Alpha-synuclein and autophagy as common steps in neurodegeneration
Ferrucci, M., Pasquali, L., Ruggieri, S. A., Paparelli, A., & Fornai, F. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.025 · Cited by 44
Common variants in PARK loci and related genes and Parkinson's disease
Chung, S. J., Armasu, S. M., Biernacka, J. M., Lesnick, T. G., Rider, D. N., Lincoln, S., Soto‐Ortolaza, A. I., Farrer, M. J., Cunningham, J. M., Rocca, W. A., et al. (2010) · Movement Disorders · doi:10.1002/mds.23376 · Cited by 42
Grubman, A., Lidgerwood, G. E., Duncan, C., Bica, L., Tan, J.-L., Parker, S. J., Caragounis, A., Meyerowitz, J., Volitakis, I., Moujalled, D., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-25 · Cited by 40
Singh, N., Haldar, S., Tripathi, A. K., McElwee, M. K., Horback, K., & Beserra, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5874 · Cited by 45
Damage in Mitochondrial DNA Associated with Parkinson's Disease
Martín-Jiménez, R., Lurette, O., & Hébert-Chatelain, É. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5398 · Cited by 42
Cryo-EM reveals mechanistic insights into lipid-facilitated polyamine export by human ATP13A2
Tomita, A., Daiho, T., Kusakizako, T., Yamashita, K., Ogasawara, S., Murata, T., Nishizawa, T., & Nureki, O. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.11.001 · Cited by 41
Marotta, N., Kim, S., & Krainc, D. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1703671 · Cited by 42
Hypoxia regulation of ATP13A2 (PARK9) gene transcription
Xu, Q., Guo, H., Zhang, X., Tang, B., Cai, F., Zhou, W., & Song, W. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07676.x · Cited by 41
Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake
de la Hera, D. P., Corradi, G. R., Adamo, H. P., & Pinto, F. D. T. (2012) · Biochemical Journal · doi:10.1042/bj20120739 · Cited by 40
Vesicular Dysfunction and the Pathogenesis of Parkinson’s Disease: Clues From Genetic Studies
Ebanks, K., Lewis, P. A., & Bandopadhyay, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01381 · Cited by 36
Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function
Anand, N., Holcom, A., Broussalian, M., Schmidt, M., Chinta, S. J., Lithgow, G. J., Andersen, J. K., & Chamoli, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104786 · Cited by 40
Cervelli, M., Averna, M., Vergani, L., Pedrazzi, M., Amato, S., Fiorucci, C., Rossi, M. N., Maura, G., Mariottini, P., Cervetto, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071756 · Cited by 39
The BAG2 protein stabilises PINK1 by decreasing its ubiquitination
Che, X., Tang, B., Wang, X., Chen, D., Yan, X., Jiang, H. N., Shen, L., Xu, Q., Wang, G., & Guo, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.086 · Cited by 39
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of parkinson disease
Covy, J. P., & Giasson, B. I. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.01.003 · Cited by 44
On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation
Tello, C., Darling, A., Lupo, V., Pérez‐Dueñas, B., & Espinós, C. (2017) · Clinical Genetics · doi:10.1111/cge.13057 · Cited by 41
Neurodegeneration with brain iron accumulation
Wiethoff, S., & Houlden, H. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00011-0 · Cited by 40
Emerging Role of Genetic Alterations Affecting Exosome Biology in Neurodegenerative Diseases
Riva, P., Battaglia, C., & Venturin, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174113 · Cited by 37
Kanninen, K. M., Grubman, A., Meyerowitz, J., Duncan, C., Tan, J.-L., Parker, S. J., Crouch, P. J., Paterson, B. M., Hickey, J. L., Donnelly, P. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058644 · Cited by 38
Huber, R. J. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0301-0 · Cited by 40
Flies with Parkinson's disease
Vanhauwaert, R., & Verstreken, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.020 · Cited by 39
Pokusa, M., & Trancikova, A. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8210734 · Cited by 39
Genetics of Movement Disorders and the Practicing Clinician; Who and What to Test for?
Fonzo, A. D., Monfrini, E., & Erro, R. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0847-1 · Cited by 37
Gene4PD: A Comprehensive Genetic Database of Parkinson’s Disease
Li, B., Zhao, G., Zhou, Q., Xie, Y., Wang, Z., Fang, Z., Lü, B., Qin, L., Zhao, Y., Zhang, R., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.679568 · Cited by 40
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 37
From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and Opportunities
Mächtel, R., Boros, F. A., Dobert, J. P., Arnold, P., & Zunke, F. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167932 · Cited by 39
Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy
Brichta, L., Garbes, L., Jędrzejowska, M., Grellscheid, S., Hölker, I., Zimmermann, K., & Wirth, B. (2008) · Human Genetics · doi:10.1007/s00439-007-0455-7 · Cited by 36
Yeast buddies helping to unravel the complexity of neurodegenerative disorders
Fruhmann, G., Seynnaeve, D., Zheng, J., Ven, K., Molenberghs, S., Wilms, T., Liu, B., Winderickx, J., & Franssens, V. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.002 · Cited by 40
Sato, S., Koike, M., Funayama, M., Ezaki, J., Fukuda, T., Ueno, T., Uchiyama, Y., & Hattori, N. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.08.006 · Cited by 39
Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules
Lanzillotta, C., & Domenico, F. D. (2021) · Biomolecules · doi:10.3390/biom11020266 · Cited by 38
Autophagy in α-Synucleinopathies—An Overstrained System
Fellner, L., Gabassi, E., Haybaeck, J., & Edenhofer, F. (2021) · Cells · doi:10.3390/cells10113143 · Cited by 45
P5B-ATPases in the mammalian polyamine transport system and their role in disease
Azfar, M., van Veen, S., Houdou, M., Hamouda, N. N., Eggermont, J., & Vangheluwe, P. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119354 · Cited by 38
Mandel, S. A., Morelli, M., Halperin, I. J. Y., & Korczyn, A. D. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0036-z · Cited by 39
Enrichment of Minor Alleles of Common SNPs and Improved Risk Prediction for Parkinson's Disease
Zhu, Z., Yuan, D., Luo, D., Lu, X., & Huang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133421 · Cited by 36
Advances in the genetics of Parkinson's disease
Rosner, S., Giladi, N., & Orr‐Urtreger, A. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00731.x · Cited by 39
Phylogenetic and in silico structural analysis of the Parkinson disease‐related kinase PINK1
Cardona, F., Sanchez-Mut, J. V., Dopazo, H., & Pérez‐Tur, J. (2011) · Human Mutation · doi:10.1002/humu.21444 · Cited by 38
Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation
Lees, A. J., & Singleton, A. B. (2007) · Neurology · doi:10.1212/01.wnl.0000265228.66664.f4 · Cited by 35
Casterton, R., Hunt, R. J., & Fanto, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.018 · Cited by 38
ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
Si, J., den Haute, C. V., Lobbestael, E., Martin, S., van Veen, S., Vangheluwe, P., & Baekelandt, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052689 · Cited by 37
The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research
Huber, R. J., Hughes, S. M., Liu, W., Morgan, A., Tuxworth, R. I., & Russell, C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165614 · Cited by 36
? - synuclein and Parkinson's disease: the first roadblock
Chua, C. E. L., & Tang, B. L. (2006) · Journal of Cellular and Molecular Medicine · doi:10.2755/jcmm010.004.04 · Cited by 34
Rose, F. D., Marotta, R., Poddighe, S., Talani, G., Catelani, T., Setzu, M. D., Solla, P., Marrosu, F., Sanna, E., Kasture, S. B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146140 · Cited by 34
Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more…
Rouaud, T., Corbillé, A.-G., Leclair‐Visonneau, L., de Lataillade, A. D. G., Lionnet, A., Preterre, C., Damier, P., & Derkinderen, P. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.07.016 · Cited by 35
ATP9A deficiency causes ADHD and aberrant endosomal recycling via modulating RAB5 and RAB11 activity
Meng, T., Chen, X., He, Z., Huang, H., Lin, S., Liu, K., Bai, G., Liu, H., Xu, M.-D., Zhuang, H., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01940-w · Cited by 34
Sharma, S., & Priya, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2340-9 · Cited by 34
Jiao, F., Meng, L., Du, K., & Li, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01195 · Cited by 33
Autophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 35
Cryo-EM structures and transport mechanism of human P5B type ATPase ATP13A2
Chen, X., Zhou, M., Zhang, S., Yin, J. Y., Zhang, P., Xuan, X., Wang, P., Liu, Z., Zhou, B., & Yang, M. (2021) · Cell Discovery · doi:10.1038/s41421-021-00334-6 · Cited by 33
Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease)
Kim, W. D., Wilson‐Smillie, M. L. D. M., Thanabalasingam, A., Lefrançois, S., Cotman, S. L., & Huber, R. J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.812728 · Cited by 37
Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis
Martin, L. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100348 · Cited by 32
Asymmetry in parkinsonism, spreading pathogens and the nose
Hobson, D. E. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.06.011 · Cited by 35
Parkinson's disease and mitochondrial gene variations: A review
Andalib, S., Vafaee, M. S., & GJEDDE, A. H. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.07.067 · Cited by 34
Mitochondrial Morphogenesis, Distribution, and Parkinson Disease: Insights From PINK1
Yang, Y., & Lu, B. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b2048c · Cited by 34
Human‐Specific Transcriptome of Ventral and Dorsal Midbrain Dopamine Neurons
Monzón‐Sandoval, J., Poggiolini, I., Ilmer, T., Wade‐Martins, R., Webber, C., & Parkkinen, L. (2020) · Annals of Neurology · doi:10.1002/ana.25719 · Cited by 32
Clinical genetics of Parkinson's disease and related disorders
Wider, C. W., & Wszołek, Z. K. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70007-5 · Cited by 32
Tomiyama, H., Kokubo, Y., Sasaki, R., Li, Y., Imamichi, Y., Funayama, M., Mizuno, Y., Hattori, N., & Kuzuhara, S. (2008) · Movement Disorders · doi:10.1002/mds.22262 · Cited by 37
Lamonaca, G., & Volta, M. (2020) · Cells · doi:10.3390/cells9051115 · Cited by 32
Yousefi, M., Peymani, M., Ghaedi, K., Irani, S., & Etemadifar, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-06539-3 · Cited by 33
Nejad, M. M., Shahidi, G. A., Rohani, M., Shojaee, S. M., Hashemi, M., Klotzle, B., Fan, J., & Elahi, E. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.023 · Cited by 31
The zebrafish homologue of Parkinson's disease ATP13A2 is essential for embryonic survival
da Fonseca, T. L., Correia, A. D., Hasselaar, W., van der Linde, H. C., Willemsen, R., & Outeiro, T. F. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.09.017 · Cited by 31
Kanninen, K. M., Grubman, A., Caragounis, A., Duncan, C., Parker, S. J., Lidgerwood, G. E., Volitakis, I., Ganio, G., Crouch, P. J., & White, A. R. (2013) · Biology Open · doi:10.1242/bio.20134804 · Cited by 31
A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death
da Fonseca, T. L., Pinho, R., & Outeiro, T. F. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw147 · Cited by 33
The effect of manganese exposure in Atp13a2-deficient mice
Fleming, S. M., Santiago, N. A., Mullin, E. J., Pamphile, S., Karkare, S., Lemkuhl, A., Ekhator, O. R., Linn, S. C., Holden, J. G., Aga, D. S., et al. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.06.005 · Cited by 31
Cooper, J. F., Spielbauer, K. K., Senchuk, M. M., Nadarajan, S., Colaiácovo, M. P., & Raamsdonk, J. M. V. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.09.001 · Cited by 35
Gründemann, J., Schlaudraff, F., & Liss, B. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-163-5_30 · Cited by 31
Self-citationZhang, F., Wu, Z., Long, F., Tan, J., Gong, N., Li, X., & Lin, C. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.927682 · Cited by 35
Guo, J., Wang, L., He, D., Yang, Q.-H. O., Duan, Z., Zhang, X., Nie, L.-L., Yan, X., & Tang, B. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0360-z · Cited by 30
Drug discovery in Parkinson's disease: update and developments in the use of cellular models
Finkbeiner, S. M., & Skibinski (2011) · International Journal of High Throughput Screening · doi:10.2147/ijhts.s8681 · Cited by 32
Tao, Q., Fan, X., Li, T., Tang, Y., Yang, D., & Le, W. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22729 · Cited by 30
ATP13A2 missense variant in Australian Cattle Dogs with late onset neuronal ceroid lipofuscinosis
Schmutz, I., Jagannathan, V., Bartenschlager, F., Stein, V. M., Gruber, A. D., Leeb, T., & Katz, M. L. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.11.015 · Cited by 31
Kouroupi, G., Antoniou, N., Prodromidou, K., Taoufik, E., & Matsas, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197113 · Cited by 32
Choi, J.-M., Hong, J.-H., Chae, M.-J., Hung, N. P., Kang, H.-S., Ma, H., & Kim, Y. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.013 · Cited by 31
Deng, H., Le, W., Shahed, J. J., Xie, W., & Jankovic, J. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.018 · Cited by 30
α - synuclein and Parkinson's disease: the first roadblock
Chua, C. E. L., & Tang, B. L. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00528.x · Cited by 33
Candidate genes for Parkinson disease: Lessons from pathogenesis
Rosa, P. D., Marini, E. S., Gelmetti, V., & Valente, E. M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.04.042 · Cited by 32
Lysosomal Proteins as a Therapeutic Target in Neurodegeneration
Donald, J. M. M., & Krainc, D. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104432 · Cited by 31
Neuronal Ceroid Lipofuscinosis—Concepts, Classification, and Avenues for Therapy
Zhang, Y., Du, B., Zou, M., Peng, B., & Rao, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70261 · Cited by 36
Synaptic Protein Alterations in Parkinson’s Disease
Pienaar, I. S., Burn, D. J., Morris, C. M., & Dexter, D. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8226-9 · Cited by 32
Martin, S., van Veen, S., Holemans, T., Demirsoy, Ş., den Haute, C. V., Baekelandt, V., Agostinis, P., Eggermont, J., & Vangheluwe, P. (2016) · Parkinson s Disease · doi:10.1155/2016/9531917 · Cited by 32
Convergent pathways in Parkinson’s disease
Cherubini, M., & Wade‐Martins, R. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2700-2 · Cited by 31
The contribution of C. elegans neurogenetics to understanding neurodegenerative diseases
Liang, J., McKinnon, I. A., & Rankin, C. H. (2020) · Journal of Neurogenetics · doi:10.1080/01677063.2020.1803302 · Cited by 30
Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms
Wildburger, N. C., Hartke, A.-S., Schidlitzki, A., & Richter, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.598446 · Cited by 30
Yong-Kee, C. J., Sidorova, E. S., Hanif, A., Perera, G., & Nash, J. E. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9259-6 · Cited by 28
What Have PINK1 and HtrA2 Genes Told Us about the Role of Mitochondria in Parkinson's Disease?
Plun‐Favreau, H., Gandhi, S., Wood‐Kaczmar, A., Deas, E., Yao, Z., & Wood, N. W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.032 · Cited by 28
LRRK2 and autophagy: a common pathway for disease
Manzoni, C. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120126 · Cited by 31
Metadata
- Authors
- Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I., & Kubisch, C.
- Affiliations
- University of Cologne (DE)
- Philipps University of Marburg (DE)
- University of Leeds (GB)
- Centro de Estudios Científicos (CL)
- University of Bonn (DE)
- King Hussein Medical Center (JO)
- Pinderfields Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Kubisch, Christian
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-09-10
- Volume
- 38
- Issue
- 10
- Pages
- 1184-1191
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2139369185
- Cited by
- 1,208
- References
- 30
- Citations by year
- 2026: 42 · 2025: 44 · 2024: 39 · 2023: 49 · 2022: 45 · 2021: 70 · 2020: 73 · 2019: 69 · 2018: 54 · 2017: 64 · 2016: 76 · 2015: 59 · 2014: 57 · 2013: 71 · 2012: 64
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion)
- Funders
- Tinker Foundation
- Wellcome Trust
- Royal Society
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Rheinische Friedrich-Wilhelms-Universität Bonn
- National Institutes of Health
- Directorate for Biological Sciences
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- ATP13A2, P-type ATPase, Kufor-Rakeb syndrome, PARK9, autosomal recessive inheritance, loss-of-function mutations, neurodegeneration, endoplasmic reticulum retention, proteasomal degradation, protein misfolding
- MeSH terms
- Adenosine Triphosphatases, Dementia, Endoplasmic Reticulum, Female, Proton-Translocating ATPases, Humans, Lysosomes, Male, Mesencephalon, Mutation, Neurons, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.